171. Wilson disease Clinical trials / Disease details

Clinical trials : 68 / Drugs : 79 - (DrugBank : 17) / Drug target genes : 3 - Drug target pathways : 28

19 trials found

diseases per page:

Showing 1 to 10 of 19 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-001015-82-DE (EUCTR)	26/11/2021	10/08/2021	Phase 3, open-label study of ALXN1840 versus standard of carein pediatric participants with Wilson d ...	A multicenter, randomized, controlled, open-label, rater-blinded study to evaluate efficacy, safety, ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 Product Code: ALXN1840 INN or Proposed INN: tiomolibdic acid Other descriptive n ...	Alexion Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 3	Serbia;United States;Czechia;Spain;Turkey;Austria;Russian Federation;United Kingdom;France;Hungary;C ...
2	EUCTR2021-001015-82-ES (EUCTR)	22/11/2021	23/08/2021	Phase 3, open-label study of ALXN1840 versus standard of carein pediatric participants with Wilson d ...	A multicenter, randomized, controlled, open-label, rater-blinded study to evaluate efficacy, safety, ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 Product Code: ALXN1840 INN or Proposed INN: tiomolibdic acid Other descriptive n ...	Alexion Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 3	United Kingdom;France;Hungary;Canada;Poland;Australia;Denmark;Netherlands;Germany;Japan;Korea, Repub ...
3	NCT05047523 (ClinicalTrials.gov)	October 6, 2021	9/9/2021	Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease	A Multicenter, Randomized, Controlled, Open-label, Rater-blinded Study to Evaluate Efficacy, Safety, ...	Wilson Disease	Drug: ALXN1840;Drug: Standard of Care	Alexion Pharmaceuticals	NULL	Recruiting	3 Years	17 Years	All	48	Phase 3	Australia;Japan;Korea, Republic of;Poland;Spain
4	EUCTR2017-004135-36-NL (EUCTR)	30/03/2020	16/10/2019	Study to Evaluate the Efficacy and Safety of ALXN1840 in pPtients with Wilson Disease.	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	United States;Portugal;Serbia;Taiwan;Hong Kong;Greece;Spain;Israel;Russian Federation;Colombia;Italy ...
5	EUCTR2017-004135-36-PT (EUCTR)	13/01/2020	26/03/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	United States;Portugal;Serbia;Hong Kong;Taiwan;Spain;Israel;Russian Federation;Colombia;France;Denma ...
6	EUCTR2017-004135-36-SE (EUCTR)	29/10/2019	16/04/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Russian Federation;Israel;Colombia;France;Austr ...
7	EUCTR2017-004135-36-DK (EUCTR)	16/10/2019	05/08/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Hong Kong;Taiwan;Spain;Russian Federation;Israel;Colombia;France;Austr ...
8	EUCTR2017-004135-36-FR (EUCTR)	14/09/2018	15/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;France;Czech Republic;Hungary;Belgi ...
9	EUCTR2017-004135-36-ES (EUCTR)	27/04/2018	22/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Phase 3	France;United States;Hungary;Czech Republic;Poland;Spain;Austria;Israel;Germany;Italy;United Kingdom ...
10	EUCTR2017-004135-36-GB (EUCTR)	23/03/2018	19/12/2017	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;France;Czech Republic;Hungary;Belgi ...

First Previous1 2Next Last